402 results on '"Boussios, Stergios"'
Search Results
2. Applying whole-genome and whole-exome sequencing in breast cancer: a review of the landscape
3. Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape
4. Stage 3 N2 Lung Cancer: A Multidisciplinary Therapeutic Conundrum
5. An overview of immune checkpoint inhibitor toxicities in bladder cancer
6. Frontiers of Ovarian Carcinosarcoma
7. Advances in adoptive T-cell therapy for metastatic melanoma
8. Systematic review of the CUP trials characteristics and perspectives for next-generation studies
9. AI-Guided Cancer Therapy for Patients with Coexisting Migraines.
10. Systematic review of fetal and placental metastases among pregnant patients with cancer
11. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol
12. Sarcoma of unknown primary: myth or reality?
13. lncRNA Biomarkers of Glioblastoma Multiforme
14. The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER registry
15. Melanoma of unknown primary: New perspectives for an old story
16. Exosomes in Renal Cell Cancer: Diagnostic and Therapeutic Nanovehicles.
17. Management of Recurrent Uterine Cervical Cancer
18. New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?
19. Large Language Models in Oncology: Revolution or Cause for Concern?
20. The Application of Radiomics and AI to Molecular Imaging for Prostate Cancer
21. A novel PD-1/PD-L1 pathway-related seven-gene signature for the development and validation of the prognosis prediction model for breast cancer
22. Immunotherapy Combined With Standard Therapies in Head and Neck Squamous Cell Carcinoma – A Meta-analysis
23. A rare case of metaplastic breast carcinoma from India: Towards precision oncology
24. Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4
25. Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
26. Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach
27. Ovarian carcinosarcoma: Current developments and future perspectives
28. Frontiers of Molecular Biology of Cancer
29. Astragaloside IV enhances the sensitivity of breast cancer stem cells to paclitaxel by inhibiting stemness
30. Review of: "A Value-Driven Future Approach to Precision Medicine for Health Sustainability in New Zealand: A Perspective"
31. Renal Cell Cancer – Insights in Drug Resistance Mechanisms
32. The integration of palliative care with oncology: the path ahead
33. Immunotherapy for advanced urothelial carcinoma (UC): rational and current evidence
34. COVID-19 Associated Mucormycosis and Cytomegalovirus Infection – A Case Report
35. Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine
36. A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives
37. Exosomes in the Diagnosis and Treatment of Renal Cell Cancer
38. Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study
39. Gestational Renal Cell Cancer – An Update
40. Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities
41. A rare case of metaplastic breast carcinoma from India: Towards precision oncology
42. Emerging Hallmarks of the Tumour Microenvironment of Gliomas and the Interplay with Immunotherapy
43. Advances in Ovarian Cancer Treatment Beyond PARP Inhibitors
44. Managing Melanoma During Pregnancy
45. Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspects
46. Clinical Challenges in the Management of Malignant Ovarian Germ Cell Tumours
47. Impact of COVID-19 on cancer services and patients’ outcomes: a retrospective single-center study
48. State-of-the-Art Molecular Oncology in UK
49. Posterior Reversible Encephalopathy Syndrome after Pazopanib Therapy
50. Clinico-Pathological Factors Determining Recurrence of Phyllodes Tumors of the Breast: The 25-Year Experience at a Tertiary Cancer Centre
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.